Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

University of Mississippi ("UM") Agreements (Detail Textuals)

University of Mississippi ("UM") Agreements (Detail Textuals) (USD $)	3 Months Ended	1 Months Ended		0 Months Ended
	Mar. 31, 2015	Jul. 31, 2013	Sep. 29, 2014 license_agreements	May 15, 2014
University Of Mississippi Agreements [Line Items]
Research and development expense	$ 37,200us-gaap_ResearchAndDevelopmentExpense
Intellectual Property \| University of Mississippi ("UM") Agreements
University Of Mississippi Agreements [Line Items]
Term of memorandum of understanding agreement		5 years
Intellectual Property \| Option Agreement
University Of Mississippi Agreements [Line Items]
Number of license agreements			3
Notice period for termination			60 days
Normal option fee waived per month by University of Mississippi				7,500
Reimbursement of sunk patent expenses			70,678
Research and development expense	$ 14,700

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References + Details